Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11638797 | PMC |
| http://dx.doi.org/10.1001/jamanetworkopen.2024.50251 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trial.
Am Heart J
September 2025
Baylor Scott and White Research Institute and HealthCare, Dallas TX. Electronic address:
Background: Current recommendations for a prophylactic (primary prevention) implantable cardioverter defibrillator (ICD) in patients with both ischemic and non-ischemic heart failure with reduced ejection fraction (HFrEF) originate from clinical trials conducted in selected patients over 20 years ago that showed an overall statistically significant survival benefit associated with a primary prevention ICD in the range of 23%-34%. The recent introduction of angiotensin receptor-neprilysin inhibitors [ARNI] and sodium glucose co-transporter 2 inhibitors [SGLT2i]) was shown to further reduce the risk of sudden cardiac death (SCD) in patients with HFrEF. Thus, there is an unmet need appropriately designed comparative effectiveness clinical trials aimed to reassess the survival benefit of a primary prevention ICD in contemporary patients with HFrEF.
View Article and Find Full Text PDFCardiac macrophages and their functions in homeostasis and injury.
Atherosclerosis
August 2025
Institute for Clinical Chemistry and Laboratory Medicine, UniversityHospital and Faculty of Medicine, TU Dresden, 01307, Dresden, Germany; National Center for Tumor Diseases, Partner Site Dresden, 01307, Dresden, Germany; Paul Langerhans Institute Dresden of the Helmholtz Center Munich, University
Due to their remarkable plasticity, macrophages can adapt to diverse environments and challenges therein, thereby exerting tissue-specific and context-specific functions. Macrophages are the most frequent immune cell population present in the heart and contribute substantially to cardiac homeostasis and function. Moreover, macrophages are key regulators throughout all stages of heart injury, acquiring diverse phenotypes that can either ameliorate or exacerbate cardiac pathology in a context-dependent manner.
View Article and Find Full Text PDFRisk Stratification in Functional Tricuspid Regurgitation: Is Nonischemic Septal Fibrosis the Missing Piece?
JACC Cardiovasc Imaging
September 2025
Cardiovascular Imaging Research Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA; Cardiovascular Imaging Unit and Cardiology Department, Cardiothoracic Department, San Raffaele Hospital, IRCCS, Milan, Italy.
A pilot study on DNA methylation changes for non-invasive molecular diagnostics in heart failure.
ESC Heart Fail
September 2025
Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania 'Luigi Vanvitelli', Naples, Italy.
Aims: The current therapeutic approach to ischaemic (IsHF) and non-ischaemic (NIsHF) heart failure (HF) mainly overlooks the underlying aetiology owing to a lack knowledge of the differential molecular pathways that contribute to HF with reduced ejection fraction (HFrEF). Alterations in myocardial DNA methylation levels have been identified as potential biomarkers for HF irrespective of its aetiology. Due to the limited availability of cardiac tissues in clinics, our goal is to determine if DNA methylation changes in circulating CD4 T lymphocytes, which are strongly involved in left ventricle remodelling, can help in differentiating IsHF and NIsHF causes among patients with HFrEF and if DNA methylation levels associate with key clinical features.
View Article and Find Full Text PDFImpact of routine repeat echocardiograms in patients hospitalized with acute decompensated heart failure without clear secondary cause.
Int J Cardiovasc Imaging
September 2025
Heart & Vascular Institute, Henry Ford Hospital Detroit, Henry Ford West Bloomfield Hospital 5, West Bloomfield, MI, USA.
Transthoracic echocardiography (TTE) at the time of acute decompensated heart failure (ADHF) may reveal significant structural and hemodynamic abnormalities that can guide clinical management. However, the impact of routine repeat TTE in uncomplicated ADHF re-admissions is yet to be established. We studied patients with repeat TTE at the time of rehospitalization for ADHF to determine downstream clinical impact.
View Article and Find Full Text PDF